KeyBank National Association
AUPH icon

KeyBank National Association’s Aurinia Pharmaceuticals AUPH Stock Holding History

KeyBank National Association’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,800
Closed -$156K – 1056
2022
Q3 		$156K Hold
20,800
– – ﹤0.01% 1001
2022
Q2 		$209K Sell
20,800
-5,285
-20% -$59.1K ﹤0.01% 994
2022
Q1 		$323K Sell
26,085
-141
-0.5% -$2.18K ﹤0.01% 888
2021
Q4 		$600K Buy
26,226
+10,026
+62% +$238K ﹤0.01% 751
2021
Q3 		$359K Hold
16,200
– – ﹤0.01% 893
2021
Q2 		$210K Hold
16,200
– – ﹤0.01% 1030
2021
Q1 		$210K Buy
+16,200
New +$235K ﹤0.01% 1017

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

KeyBank National Association's AUPH Position: Q4 2022 in Review

KeyBank National Association sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 20,800 shares — an estimated $156K sold.

KeyBank National Association first reported a position in AUPH in Q1 2021 and held it in 7 quarters. The position peaked at $600K in Q4 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • KeyBank National Association reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • KeyBank National Association sold 20,800 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $156K.
  • KeyBank National Association first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • KeyBank National Association's Aurinia Pharmaceuticals position peaked at $600K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on KeyBank National Association's 13F filing for Q4 2022, filed 31 Jan 2023.